Abstract 12805: Incidence and Predictors of Myocardial Infarction or Stent Thrombosis in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention

Johny Nicolas(Cardiovascular Institute of the South), Roxana Mehran(Mount Sinai Hospital), Daniel Feldman(Cardiovascular Institute of the South), Annapoorna Kini(Mount Sinai Medical Center), Samin K. Sharma(Mount Sinai Health System), Nicholas L. Pitaro(Icahn School of Medicine at Mount Sinai), Birgit Vogel(Cardiovascular Institute of the South), David Power(Cardiovascular Institute of the South), Davis Jones(Cardiovascular Institute of the South), Davide Cao(Cardiovascular Institute of the South), Anton Camaj(Columbia University Irving Medical Center), Alessandro Spirito(University of Bern), Joseph Sweeny(Mount Sinai Hospital), Zhongjie Zhang(Shanxi Medical University), David Youssef(Icahn School of Medicine at Mount Sinai), Frans Beerkens(Icahn School of Medicine at Mount Sinai), Madison Edens(Icahn School of Medicine at Mount Sinai), George Dangas(Mount Sinai Hospital), Samantha Sartori(Icahn School of Medicine at Mount Sinai)
Circulation
November 8, 2022
10.1161/circ.146.suppl_1.12805
Cited by 1

Related Papers

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|734
Characterization of Myocardial Injury in Patients With COVID-19
|Journal of the American College of Cardiology|2020|429
Coronary In-Stent Restenosis
|Journal of the American College of Cardiology|2022|397
Long-Term Outcome of Percutaneous Coronary Intervention for Chronic Total Occlusions
|JACC: Cardiovascular Interventions|2011|310